Friday, AbbVie Inc ABBV reported first-quarter adjusted EPS of $2.31, down 6.1% Y/Y, beating the consensus of $2.23.
Net revenues reached $12.31 billion, up 0.7%, beating the consensus of $11.92 billion. Sales were up 1.6% on an operational basis.
“First quarter results were well ahead of our expectations, driven by excellent performance from our ex-Humira growth platform,”…

#abbvieincabbv#eps#robertmichael#humira#rinvoq#abbvie#landosbiopharmainc#imbruvica